Followers | 228 |
Posts | 14888 |
Boards Moderated | 1 |
Alias Born | 03/29/2014 |
Saturday, February 12, 2022 1:12:29 PM
Regarding the UCLA trial, many here will remember that Linda Liau herself told me in person several years ago at a presentation she, and several other UCLA neurology staff members attended including P. Leia Nghiemphu, MD. It was a pretty small event, and I had a chance to talk with LL alone for about five minutes (she revealed nothing material to me… I think NWBO was writing the SAP at the time?); and I asked her if the autologous dendritic cell vaccine being used in the recurrent GBM trial was DCVax-L to which she replied yes. She said that because Northwest was not sponsoring the trial, nor making the vaccine (they had very little money), UCLA was making the vaccine themselves, which they could do at UCLA because of their relationship with the company and involvement with DCVax-L. Something like that. I also spoke with Dr. N for maybe ten minutes after the presentation who confirmed that it was indeed DCVax. To be clear, I told both doctors that I was an NWBO shareholder up front.
Ex knows all this, as well as the other evidence gathered, so I doubt he’s questioning if DCVax-L is the vaccine being used in the recurrent GBM trial any more.
Now… regarding that dendritic cell vaccine being used in a combo lung trial.
Color: back around maybe 2014?, my neighbor’s son (he was the valedictorian of his high school) was accepted into UCLA. He wanted to go into medicine. When he’d come home for a visit, I’d occasionally chat with him about what he was interested in pursuing there. He had said he was really interested in “immunotherapy”. Well of course, I asked if he’d met Dr Prins and Dr Liau. I told him all about DCVax-L and UCLA’s involvement.
Fast forward: he is now working under Dr Prins and a lung doctor and they are using DCVax-L in some lung studies. He told me this about a year ago, and referred to the vaccine UCLA was using as DCVax-L… for what that’s worth. I don’t see him that often, and when I do, it’s usually just a quick wave, and he hasn’t told me anything material; and we have not discussed anything related to the P3 trial.
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM